Recurring Weakness in Rhabdomyolysis Following Pfizer–BioNTech Coronavirus Disease 2019 mRNA Vaccination

Rhabdomyolysis is a well-known clinical syndrome of muscle injury. Rhabdomyolysis following coronavirus disease 2019 (COVID-19) vaccination has recently been reported. The patients’ weakness gradually subsided and did not recur. Rhabdomyolysis associated with COVID-19 vaccination has not been assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Motoya, Niwa, Jun-Ichi, Doyu, Manabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230860/
https://www.ncbi.nlm.nih.gov/pubmed/35746543
http://dx.doi.org/10.3390/vaccines10060935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230860/
https://www.ncbi.nlm.nih.gov/pubmed/35746543
http://dx.doi.org/10.3390/vaccines10060935

Ejemplares similares